Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis (2019)
- Authors:
- USP affiliated authors: BONATO, PIERINA SUELI - FCFRP ; LANCHOTE, VERA LUCIA - FCFRP ; TAKAYANAGUI, OSVALDO MASSAITI - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.1093/cid/ciz085
- Subjects: NEUROCISTICERCOSE; ANTIPARASITÁRIOS; ANTI-HELMÍNTICOS; CISTOS
- Keywords: Albendazole; Albendazole sulfoxide; Praziquantel; Neurocysticercosis
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical Infectious Diseases
- ISSN: 1058-4838
- Volume/Número/Paginação/Ano: v. 69, n. 11, p. 1996-2002, 2019
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
ARROYO, Gianfranco et al. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis. Clinical Infectious Diseases, v. 69, n. 11, p. 1996-2002, 2019Tradução . . Disponível em: https://doi.org/10.1093/cid/ciz085. Acesso em: 29 dez. 2025. -
APA
Arroyo, G., Bustos, J. A., Lescano, A. G., Gonzales, I., Saavedra, H., Rodriguez, S., et al. (2019). Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis. Clinical Infectious Diseases, 69( 11), 1996-2002. doi:10.1093/cid/ciz085 -
NLM
Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Rodriguez S, Pretell EJ, Bonato PS, Lanchote VL, Takayanagui OM, Horton J, Gonzalez AE, Gilman RH, Garcia HH. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis [Internet]. Clinical Infectious Diseases. 2019 ; 69( 11): 1996-2002.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1093/cid/ciz085 -
Vancouver
Arroyo G, Bustos JA, Lescano AG, Gonzales I, Saavedra H, Rodriguez S, Pretell EJ, Bonato PS, Lanchote VL, Takayanagui OM, Horton J, Gonzalez AE, Gilman RH, Garcia HH. Albendazole sulfoxide plasma levels and efficacy of antiparasitic treatment in patients with parenchymal neurocysticercosis [Internet]. Clinical Infectious Diseases. 2019 ; 69( 11): 1996-2002.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1093/cid/ciz085 - Simultaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma
- Análise do albendazol sulfóxido e albendazol sulfona em plasma empregando LC-MS/MS
- Medical management of neurocysticercosis
- Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis
- Silmutaneous liquid chromatography-tandem mass spectrometric determination of albendazole sulfoxide and albendazole sulfone in plasma
- Simultaneous determination of albendazole metabolites, praziquantel and its metabolite in plasma by high-performance liquid chromatography-electrospray mass spectrometry
- Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis
- Enantioselective renal excretion of albendazole metabolites in patients with neurocysticercosis
- Quantificação cromatográfica da cafeína e metabólitos em urina para avaliação da atividade CYP1A2
- Enantioselective analysis of praziquantel and trans-4-hydroxypraziquantel in human plasma by chiral LC-MS/MS: application to pharmacokinetics
Informações sobre o DOI: 10.1093/cid/ciz085 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
002978353.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
